CN Stock MarketDetailed Quotes

002275 Guilin Sanjin Pharmaceutical

Watchlist
  • 15.90
  • +0.94+6.28%
Market Closed Dec 27 15:00 CST
9.34BMarket Cap22.88P/E (TTM)

Guilin Sanjin Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Guilin Sanjin Pharmaceutical Q3 2024 Earnings Date

Currency：CNYOct 30, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
506.37M
--
+15.71%
EPS
--
0.14
--
--
Analyst Rating
Strong Buy

Dec 28, 2024

Guilin Sanjin Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/FY -- / 2.481B --
-- 2024/FY -- / 2.246B --
-- 2023/FY 2.172B / 2.296B --
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 2.481B--
--2024/FY-- / 2.246B--
--2023/FY2.172B / 2.296B--
--------
--------

Unlock Free Earnings Estimates

Guilin Sanjin Pharmaceutical Earnings Reports

  • Guilin Sanjin: Report for the third quarter of 2024

    Oct 30 00:00

  • Guilin Sanjin: Semi-Annual Report 2024

    Aug 29 00:00

  • Guilin Sanjin: 2024 Semi-Annual Report Summary

    Aug 29 00:00

  • Guilin Sanjin Pharmaceutical: 2024 FIRST QUARTER REPORT (CORRECTED)

    Apr 27 00:00

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 28, 2024

    Strong Buy

    • Strong Buy

      57.14%

    • Buy

      42.86%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme Traditional Chinese Medicine Concept
    Traditional Chinese Medicine Concept
    Intraday+0.83%
    Monoclonal Antibody Concept
    Monoclonal Antibody Concept
    Intraday+0.71%
    Health China
    Health China
    Intraday+0.41%